Description

Pharmacokinetics and Pharmacodynamics:

Fenofibrate belongs to the class of medications known as fibric acid derivatives. It acts primarily by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), which regulates lipid metabolism. Fenofibrate reduces triglyceride levels by enhancing lipolysis and decreasing the synthesis of triglycerides in the liver. Additionally, it increases high-density lipoprotein (HDL) cholesterol levels and may modestly lower low-density lipoprotein (LDL) cholesterol levels.

Drug Classification:

Fenofibrate is classified as a lipid-lowering agent and is commonly used to treat hyperlipidemia and dyslipidemia. It is indicated for patients with elevated triglyceride levels and mixed dyslipidemia, often in combination with dietary modifications and other lipid-lowering medications.

Formulations:

Our Fenofibrate Range is available in capsule form, with a strength of 200 mg per capsule. Each capsule contains the precise dosage of fenofibrate to effectively manage lipid disorders and improve cardiovascular health.

Indications:

Fenofibrate capsules are indicated for the following conditions:

Hypertriglyceridemia: Fenofibrate is used to reduce elevated triglyceride levels in patients with hypertriglyceridemia, including those with Fredrickson Types IV and V hyperlipidemia.

Mixed Dyslipidemia: Fenofibrate may be prescribed to treat mixed dyslipidemia characterized by elevated triglycerides and low HDL cholesterol levels.

Atherosclerosis Prevention: Fenofibrate may be considered for cardiovascular risk reduction in patients at high risk of atherosclerotic cardiovascular disease, particularly those with combined dyslipidemia and metabolic syndrome.

Usage:

Fenofibrate capsules should be taken orally with water, preferably with meals to enhance absorption and reduce gastrointestinal side effects. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional.

Dosage:

The recommended dosage of fenofibrate may vary depending on the patient’s lipid profile and response to treatment. Typically, the initial dose ranges from 145 mg to 200 mg once daily. Dosage adjustments may be necessary based on individual patient factors and treatment goals.

Side Effects:

While fenofibrate is generally well-tolerated, some individuals may experience side effects, including:

• Gastrointestinal disturbances (e.g., abdominal pain, diarrhea, nausea)

• Headache

• Myopathy (muscle pain or weakness)

• Elevated liver enzymes

• Gallstones

If you experience any severe or persistent side effects, contact your healthcare provider for further evaluation and management.

Packing Specifications:

Our Fenofibrate capsules are available in blister packs containing 30 capsules each, ensuring convenience and compliance with prescribed regimens.

Trust AIT Pharmaceuticals Division for reliable and effective pharmaceutical solutions. With our Fenofibrate Range, you can take proactive steps to manage lipid disorders and protect cardiovascular health.